VIRACTA THERAPEUTICS INC (VIRX)
US92765F1084 - Common Stock
| MRQ (2024-3-31) | 2023 (2023-12-31) | 2022 (2022-12-31) | 2021 (2021-12-31) | 2020 (2020-12-31) | ||||
|---|---|---|---|---|---|---|---|---|
| ASSETS | ||||||||
| Current Assets | ||||||||
| Cash Equivalents | 12.06M | 12.32M | 36.80M | 103.60M | 20.40M | |||
| Marketable Securities | 27.50M | 41.37M | 54.30M | N/A | N/A | |||
| Receivables | N/A | 281.00K | N/A | N/A | N/A | |||
| Other Current Assets | 1.39M | 992.00K | 2.70M | 1.70M | 1.70M | |||
| Total Current Assets | 40.95M | 54.96M | 93.70M | 105.30M | 22.10M | |||
| Non-Current Assets | ||||||||
| PPE Net | 338.00K | 464.00K | 400.00K | 900.00K | 300.00K | |||
| Other Non-Current Assets | 44.00K | 1.26M | 1.80M | 2.40M | 800.00K | |||
| Total Non-Current Assets | 382.00K | 1.73M | 2.30M | 3.30M | 1.10M | |||
| TOTAL ASSETS | 41.33M | 56.69M | 96.00M | 108.60M | 23.20M | |||
| LIABILITIES | ||||||||
| Current Liabilities | ||||||||
| Short Term Debt | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |||
| Current Portion Of LT Debt. | 18.68M | 25.27M | N/A | 0.00 | 0.00 | |||
| Accrued Expenses | 9.16M | 10.66M | 7.50M | 6.20M | 2.80M | |||
| Accounts Payable | 2.41M | 2.44M | 2.50M | 2.90M | 500.00K | |||
| Other Current Liabilities | N/A | N/A | N/A | N/A | N/A | |||
| Total Current Liabilities | 30.25M | 38.37M | 10.00M | 9.10M | 3.30M | |||
| Non-Current Liabilities | ||||||||
| Long Term Debt | 0.00 | 0.00 | 24.90M | 4.80M | 0.00 | |||
| Other Non-Current Liabilities | N/A | N/A | 0.00 | 300.00K | 0.00 | |||
| Total Non-Current Liabilities | 0.00 | 0.00 | 24.90M | 5.10M | 0.00 | |||
| TOTAL LIABILITIES | 30.25M | 38.37M | 34.90M | 14.20M | 3.30M | |||
| SHAREHOLDERS' EQUITY | ||||||||
| Retained Earnings | -275.07M | -265.93M | -214.90M | -165.70M | -704.40M | |||
| Additional Paid In Capital | 280.70M | 278.79M | 270.70M | 254.60M | 718.80M | |||
| Common Shares | 5.46M | 5.46M | 5.50M | 5.50M | 5.50M | |||
| Other Shareholders' Equity | -6.00K | 9.00K | -200.00K | N/A | 0.00 | |||
| Shares Outstanding | 39.27M | 39.09M | 38.30M | 37.40M | 5.20M | |||
| Tangible Book Value per Share | 0.14 | 0.33 | 1.45 | 2.38 | 2.77 | |||
| Total Shareholders' Equity | 11.08M | 18.32M | 61.10M | 94.40M | 19.90M | |||
| TOTAL LIABILITIES AND EQUITY | 41.33M | 56.69M | 96.00M | 108.60M | 23.20M | |||
| Statistics | ||||||||
| Debt/Equity | N/A | N/A | 0.41 | 0.05 | N/A | |||
| Current Ratio | 1.35 | 1.43 | 9.37 | 11.57 | 6.70 | |||
| Return On Assets (ROA) | -116.09% | -90.06% | -51.25% | -105.67% | -93.15% | |||
| Return On Equity (ROE) | -433.09% | -278.72% | -80.52% | -121.57% | -108.59% | |||
All data in USD